Back to search
Heterozygous or Homozygous Familial Hypercholesterolemia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Heterozygous or Homozygous Familial Hypercholesterolemia trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Heterozygous or Homozygous Familial Hypercholesterolemia trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The main purpose of this study is to describe the safety and tolerability of 80 weeks of subcutaneous (SC) evolocumab when added to standard of care in children…
To evaluate the safety and efficacy of extended dosing with mipomersen (ISIS 301012) in participants with familial hypercholesterolemia or severe hypercholester…